Evidence map›Paper›PMID 28592538›Full record

ArticleJournal of virology2017

Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for

M Ruiz-Riol, D Berdnik, A Llano, B Mothe, C Gálvez, S Pérez-Álvarez, B Oriol-Tordera, A Olvera, S Silva-Arrieta, M Meulbroek and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. IL-27 effects on HIVFrontiers in virology (Lausanne, Switzerland) · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. T-Follicular-Like CD8Frontiers in immunology · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

M Ruiz-RiolIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
D BerdnikDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
A LlanoIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
B MotheIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
C GálvezIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
S Pérez-ÁlvarezIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
B Oriol-TorderaIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
A OlveraIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
S Silva-ArrietaIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
M MeulbroekProjecte dels NOMS-Hispanosida BCN Checkpoint, Barcelona, Spain.
F PujolProjecte dels NOMS-Hispanosida BCN Checkpoint, Barcelona, Spain.
J CollIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
J Martinez-PicadoIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
C GanozaIMPACTA, Lima, Peru.
J SanchezIMPACTA, Lima, Peru.
G GómezUniversitat Politècnica de Catalunya-Barcelona Tech, Barcelona, Spain.
T Wyss-CorayDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
C BranderIrsiCaixa, AIDS Research Institute, Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain cbrander@irsicaixa.es.
Hospital Universitari Germans Trias i Pujol · ESIrsiCaixa · ESAsociación Civil Impacta Salud y Educación · PEStanford University · USUniversitat Autònoma de Barcelona · ESInstitució Catalana de Recerca i Estudis Avançats · ESUniversitat Politècnica de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intact and broad immune cell effector functions and specific individual cytokines have been linked to HIV disease outcome, but their relative contribution to HIV control remains unclear. We asked whether the proteome of secreted cytokines and signaling factors in peripheral blood can be used to discover specific pathways critical for host viral control. A custom glass-based microarray, able to measure >600 plasma proteins involved in cell-to-cell communication, was used to measure plasma protein profiles in 96 HIV-infected, treatment-naive individuals with high (>50,000) or low (<10,000 HIV RNA copies/ml) viral loads. Univariate and regression model analysis demonstrate that plasma levels of soluble interleukin-27 (IL-27) are significantly elevated in individuals with high plasma viremia (

Indexed as

Viral LoadBlood ProteinsGene Expression ProfilingHIVHIV InfectionsHumansInterleukinsLeukocytes, MononuclearProtein Array AnalysisReceptors, InterleukinBlood ProteinsIL27RA protein, humanInterleukinsMYDGF protein, humanReceptors, InterleukincommunicomeHIVHIV replication controlIL-27 cytokinesoluble communication factorsTh17 signalingWnt signaling

Identifiers

PMID28592538
PMCPMC5533920
OpenAlexW2624493522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.